Achieve life sciences to announce first quarter 2023 financial results and host conference call and webcast on may 9, 2023

Seattle and vancouver, british columbia, april 26, 2023 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its first quarter 2023 financial results and provide an update on the cytisinicline development program on tuesday, may 9, 2023 at 4:30 pm edt.
ACHV Ratings Summary
ACHV Quant Ranking